Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-28

FDA Approved: BIJUVA — Original Application (Mayne Pharma)

View source ↗

Summary

The FDA approved BIJUVA, a fixed-dose combination of estradiol and progesterone from Mayne Pharma, for relief of moderate to severe vasomotor symptoms due to me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIJUVA (Estradiol and Progesterone)

Snippet

ORIG AP for BIJUVA (ESTRADIOL AND PROGESTERONE)